Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

W. Takayama; T. Asano; S. Kobayashi; S. Nakagouri; T. Kenmochi; S. Okazumi; A. Takeda; T. Fukunaga; K. Iwasaki; K. Shutou; H. Matsuzaki; H. Aoyama; K. Shinotou; T. Kouno; K. Isono

Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

W. Takayama, T. Asano, S. Kobayashi, S. Nakagouri, T. Kenmochi, S. Okazumi, A. Takeda, T. Fukunaga, K. Iwasaki, K. Shutou, H. Matsuzaki, H. Aoyama, K. Shinotou, T. Kouno, K. Isono

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

1 被引用数 (Scopus)

抄録

For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.

本文言語	英語
ページ（範囲）	867-871
ページ数	5
ジャーナル	Gan to kagaku ryoho. Cancer & chemotherapy
巻	25
号	6
出版ステータス	出版済み - 05-1998
外部発表	はい

All Science Journal Classification (ASJC) codes

医学一般

他のファイルとリンク

フィンガープリント

「Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Takayama, W., Asano, T., Kobayashi, S., Nakagouri, S., Kenmochi, T., Okazumi, S., Takeda, A., Fukunaga, T., Iwasaki, K., Shutou, K., Matsuzaki, H., Aoyama, H., Shinotou, K., Kouno, T., & Isono, K. (1998). Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE). Gan to kagaku ryoho. Cancer & chemotherapy, 25(6), 867-871.

@article{599c673905004f11a3b8301d0281a6de,

title = "Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)",

abstract = "For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.",

author = "W. Takayama and T. Asano and S. Kobayashi and S. Nakagouri and T. Kenmochi and S. Okazumi and A. Takeda and T. Fukunaga and K. Iwasaki and K. Shutou and H. Matsuzaki and H. Aoyama and K. Shinotou and T. Kouno and K. Isono",

year = "1998",

month = may,

language = "English",

volume = "25",

pages = "867--871",

journal = "Gan to kagaku ryoho. Cancer & chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "6",

}

Takayama, W, Asano, T, Kobayashi, S, Nakagouri, S, Kenmochi, T, Okazumi, S, Takeda, A, Fukunaga, T, Iwasaki, K, Shutou, K, Matsuzaki, H, Aoyama, H, Shinotou, K, Kouno, T & Isono, K 1998, 'Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 25, no. 6, pp. 867-871.

TY - JOUR

T1 - Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

AU - Takayama, W.

AU - Asano, T.

AU - Kobayashi, S.

AU - Nakagouri, S.

AU - Kenmochi, T.

AU - Okazumi, S.

AU - Takeda, A.

AU - Fukunaga, T.

AU - Iwasaki, K.

AU - Shutou, K.

AU - Matsuzaki, H.

AU - Aoyama, H.

AU - Shinotou, K.

AU - Kouno, T.

AU - Isono, K.

PY - 1998/5

Y1 - 1998/5

N2 - For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.

AB - For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.

UR - http://www.scopus.com/inward/record.url?scp=0032059093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032059093&partnerID=8YFLogxK

M3 - Article

C2 - 9617325

AN - SCOPUS:0032059093

SN - 0385-0684

VL - 25

SP - 867

EP - 871

JO - Gan to kagaku ryoho. Cancer & chemotherapy

JF - Gan to kagaku ryoho. Cancer & chemotherapy

IS - 6

ER -